JP Morgan Chase
NVAX icon

JP Morgan Chase’s Novavax NVAX Stock Holding History

JP Morgan Chase’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-46,500
Closed -$403K – 7666
2025
Q3 		$403K Buy
+46,500
New +$362K ﹤0.01% 5154
2024
Q4 		– Sell
-600
Closed -$7.58K – 7623
2024
Q3 		$7.58K Buy
+600
New +$7.75K ﹤0.01% 6413
2024
Q2 		– Sell
-230,000
Closed -$1.1M – 7637
2024
Q1 		$1.1M Sell
230,000
-250,000
-52% -$1.16M ﹤0.01% 4277
2023
Q4 		$2.3M Sell
480,000
-5,000
-1% -$30.6K ﹤0.01% 3733
2023
Q3 		$3.51M Sell
485,000
-115,000
-19% -$919K ﹤0.01% 3097
2023
Q2 		$4.46M Buy
600,000
+580,000
+2,900% +$4.56M ﹤0.01% 2948
2023
Q1 		$139K Sell
20,000
-976,900
-98% -$8.99M ﹤0.01% 5269
2022
Q4 		$10.2M Buy
996,900
+670,000
+205% +$11.8M ﹤0.01% 2229
2022
Q3 		$5.95M Sell
326,900
-293,100
-47% -$12.7M ﹤0.01% 2594
2022
Q2 		$31.9M Buy
620,000
+230,000
+59% +$11.9M ﹤0.01% 1295
2022
Q1 		$28.7M Buy
390,000
+247,800
+174% +$22.1M ﹤0.01% 1494
2021
Q4 		$20.3M Buy
142,200
+139,700
+5,588% +$24M ﹤0.01% 1821
2021
Q3 		$518K Hold
2,500
– – ﹤0.01% 4698
2021
Q2 		$531K Hold
2,500
– – ﹤0.01% 4655
2021
Q1 		$453K Sell
2,500
-700
-22% -$139K ﹤0.01% 4736
2020
Q4 		$357K Buy
+3,200
New +$340K ﹤0.01% 4557
2019
Q3 		– Sell
-35,000
Closed -$216K – 5886
2019
Q2 		$216K Sell
35,000
-500
-1% -$3.94K ﹤0.01% 4638
2019
Q1 		$391K Buy
+35,500
New +$1.12M ﹤0.01% 4326

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's NVAX Position: Q1 2026 in Review

JP Morgan Chase increased its Novavax (NVAX) stake by 4.1% in Q1 2026, buying an estimated $27.1K and bringing the position to 75,200 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #4881.

JP Morgan Chase first reported a position in NVAX in Q2 2013 and has held it in 50 quarters since. The position peaked at $83.8M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • JP Morgan Chase held 75,200 shares of Novavax worth $608K as of Q1 2026.
  • JP Morgan Chase bought 2,995 Novavax shares in Q1 2026, an estimated $27.1K.
  • Novavax made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4881 holding.
  • JP Morgan Chase first reported a position in Novavax in Q2 2013 and has held it in 50 quarters since.
  • JP Morgan Chase's Novavax position peaked at $83.8M in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.